Quick-Neuron™ Cholinergic – Maintenance Medium

Human iPSC-derived microglia are widely used in applications including neuroinflammation research, neurodegenerative disease modeling, drug discovery, toxicity screening, and microglia–neuron or microglia–astrocyte co-culture systems. Their reproducibility and human relevance make them well suited for both academic and translational research.

Yes. Quick-Glia™ human iPSC-derived microglia are cryopreserved and delivered as off-the-shelf microglia that can be thawed and plated directly into culture. The cells mature rapidly post-thaw and are ready for functional assays within approximately one week, streamlining experimental timelines.

Compared to primary microglia, iPSC-derived microglia offer greater consistency, scalability, and experimental reproducibility. While primary microglia are limited by donor variability and availability, human iPSC-derived microglia provide an off-the-shelf alternative that enables standardized assays, repeatable workflows, and reliable data generation across experiments.

iPSC-derived microglia are human microglial cells generated from induced pluripotent stem cells (iPSCs). These cells recapitulate key molecular, morphological, and functional characteristics of human microglia, making them a powerful in vitro model for studying microglial biology, neuroinflammation, and neurodegenerative disease.